The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
Pierre
P
Chauvin
Daniel
D
Ekra
Stanley A
SA
Plotkin
D002353:Carrier State; D003365:Costs and Cost Analysis; D005260:Female; D006509:Hepatitis B / Q000191:economics / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000097:blood; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious
D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines